z-logo
open-access-imgOpen Access
A novel rat model of foreign body osteomyelitis for evaluation of antimicrobial efficacy
Author(s) -
Cassandra L. Brinkman,
Suzannah M. Schmidt-Malan,
Melissa J. Karau,
Robin Patel
Publication year - 2019
Publication title -
journal of experimental and applied animal sciences/journal of experimental and applied animal sciences
Language(s) - English
Resource type - Journals
eISSN - 2314-5684
pISSN - 2314-5692
DOI - 10.20454/jeaas.2019.1555
Subject(s) - staphylococcus epidermidis , staphylococcus aureus , osteomyelitis , foreign body , microbiology and biotechnology , orthopedic surgery , discontinuation , antimicrobial , medicine , staphylococcal infections , antibiotics , animal model , vancomycin , biology , bacteria , surgery , genetics
The most common organism-type causing orthopedic foreign body infection is the staphylococci, of which Staphylococcus aureus and Staphylococcus epidermidis are especially common. These organisms form biofilms on orthopedic foreign body surfaces, rendering such infections challenging and time consuming to treat. Our group evaluates novel therapeutics for orthopedic foreign body infection in animal models. A current limitation of most animal models is that that they only allow for the removal of one sample per animal, at the time of sacrifice. Herein, we describe a novel rat model of foreign body osteomyelitis that allows removal of foreign bodies at different time points, from the same infected animal. We demonstrate that this model can be used for both S. aureus and S. epidermidis orthopedic foreign body infection, with 3.56, 3.60 and 5.51 log10 cfu/cm2 S. aureus recovered at four, five and six weeks, respectively, after infection, and 2.08, 2.17 and 2.62 log10 cfu/cm2 S. epidermidis recovered at four, five and six weeks, respectively, after infection. We evaluated the model with S. aureus infection treated with rifampin 25 mg/kg twice daily for 21 days. Using quantitative cultures, we were no longer able to detect bacteria as of the 14th day of treatment with bacteria becoming detectable again 7 days following the discontinuation of rifampin a period. This novel model allows monitoring of evolution of infection at the infection site in the same animal.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here